Filing Details
- Accession Number:
- 0001140361-24-038770
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2024-08-27 21:00:24
- Reporting Period:
- 2024-08-23
- Accepted Time:
- 2024-08-27 21:00:24
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1368514 | Adma Biologics Inc. | ADMA | Biological Products, (No Disgnostic Substances) (2836) | 562590442 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1733094 | Young Kwon | C/O Adma Biologics, Inc. 465 State Route 17 Ramsey NJ 07446 | No | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2024-08-23 | 60,000 | $18.26 | 241,441 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct |
Footnotes
- The price reported in Column 4 is the weighted average price. These shares were sold in multiple transactions at prices ranging from $18.25 to $18.27. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.
- Includes, as of the transaction date, (i) 12,020 restricted stock units ("RSUs") granted on February 26, 2024, which will vest in full on February 26, 2025, subject to the Reporting Person's continued service as of the applicable vesting date; and (ii) 229,421 shares of common stock owned by the Reporting Person.